About Janssen

Janssen – is the new name for Tibotec, a division of Janssen-Cilag Ltd. Janssen is now the name for all of the pharmaceutical companies of Johnson & Johnson. Janssen is a leader in traditional and biological medicines in a range of specialties including: mental health, neurology, oncology, immunology and infectious diseases.

Our infectious diseases compounds were developed by the research and development company Tibotec R&D which is now part of the Johnson & Johnson family of companies.

The Johnson & Johnson Family of Companies is made up of around 250 healthcare companies which are active worldwide.

Global virology heritage

Janssen continues to build on the dreams of its earliest founders: to deliver innovative medications and diagnostics for patients in need via a sustainable business. With a heritage of innovative science, uniquely combined with an impassioned commitment to meeting the needs of HIV patients, Janssen is setting the stage for positive change in HIV/ AIDS and infectious disease.

From its beginnings in HIV research, Janssen has evolved into a global virology research company with a promising pipeline that offers new hope for patients affected by serious conditions, such as HIV/AIDS and hepatitis.

Our mission is:

To extend lives, to enhance medical and diagnostic care, and to improve the quality of life for patients worldwide. We are here to make a difference.

To find out more about Janssen’s work around the world, please download our corporate brochure
by clicking here.